Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Telix Pharmaceuticals, an Australian radiopharmaceutical biotech company, withdrew its $202 million US IPO plan. Similarly, Israeli 3D printing company XJet also pulled its $6 million US IPO. Telix Pharmaceuticals had priced a $200 million IPO in the US but abandoned the plan, affecting the summer resurgence of biotech IPOs.
Radiopharma drugmaker Telix pulls US IPO plans https://t.co/aDlrHwJ6LU by @NedPagliarulo
Investors celebrating the summer resurgence of biotech IPOs might want to put the champagne back on ice, after Telix Pharmaceuticals made the last-minute decision to pull its own Nasdaq listing. https://t.co/UVQsVd0YtX
Days after #radiopharmaceuticals company @TelixPharma priced a $200 million IPO in the US, it has abandoned the plan. $TLX https://t.co/9xVSz9lcaW https://t.co/1uumjYbBEU
